未登录

M

Michael Lebens

university of gothenburg

H指数:32

被引数:3,349

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Influenza A Virus H7 nanobody recognizes a conserved immunodominant epitope on hemagglutinin head and confers heterosubtypic protection

流感A病毒H7纳米抗体识别血凝素头部的一个保守优势表位，并赋予异亚型保护。

NATURE COMMUNICATIONS

IF15.7

2025-01-093

OA

Cholera intoxication of human enteroids reveals interplay between decoy and functional glycoconjugate ligands

IF3.3

2023-08-253

OAAI

Bacterial travellers' diarrhoea: A narrative review of literature published over the past 10 years

TRAVEL MEDICINE AND INFECTIOUS DISEASE

IF4.7

2022-05-0124

OAAI

Characterization of the ganglioside recognition profile of Escherichia coli heat-labile enterotoxin LT-IIc

大肠杆菌热不稳定肠毒素lt-iic的神经节苷脂识别特征

IF3.3

2021-12-245

OAAI

Immune responses against oxidized LDL as possible targets for prevention of atherosclerosis in systemic lupus erythematosus

VASCULAR PHARMACOLOGY

IF3.5

2021-10-016

OAAI

Active immunization with PD1-derived mimotope-Combination immunotherapy against Her-2/neu-expressing tumors

CANCER RESEARCH

IF16.6

2020-08-150

PRE

A New Strategy Toward B Cell-Based Cancer Vaccines by Active Immunization With Mimotopes of Immune Checkpoint Inhibitors

FRONTIERS IN IMMUNOLOGY

IF5.9

2020-05-2726

OAAI

Alpha-galactosylceramide enhances mucosal immunity to oral whole-cell cholera vaccines

MUCOSAL IMMUNOLOGY

IF7.6

2019-07-0118

OAAI

Proteomic analysis of cholera toxin adjuvant-stimulated human monocytes identifies Thrombospondin-1 and Integrin-β1 as strongly upregulated molecules involved in adjuvant activity

SCIENTIFIC REPORTS

IF3.9

2019-02-268

OAAI

Requirement for Cyclic AMP/Protein Kinase A-Dependent Canonical NFκB Signaling in the Adjuvant Action of Cholera Toxin and Its Non-toxic Derivative mmCT

FRONTIERS IN IMMUNOLOGY

IF5.9

2019-02-199

OAAI

B cells treated with CTB-p210 acquire a regulatory phenotype in vitro and reduce atherosclerosis in apolipoprotein E deficient mice

VASCULAR PHARMACOLOGY

IF3.5

2018-12-016

PREAI

A Novel Nonantibiotic, lgt-Based Selection System for Stable Maintenance of Expression Vectors in Escherichia coli and Vibrio cholerae

APPLIED AND ENVIRONMENTAL MICROBIOLOGY

IF3.7

2018-02-157

OAAI

GM1 ganglioside-independent intoxication by Cholera toxin

IF4.9

2018-02-1259

OAAI

Surface expression of Helicobacter pylori HpaA adhesion antigen on Vibrio cholerae, enhanced by co-expressed enterotoxigenic Escherichia coli fimbrial antigens

MICROBIAL PATHOGENESIS

IF3.5

2017-04-0131

PREAI

Biochemical and structural characterization of the novel sialic acid-binding site of Escherichia coli heat-labile enterotoxin LT-IIb

BIOCHEMICAL JOURNAL

IF4.3

2016-10-278

OAAI

Retrospective Analysis of Serotype Switching of Vibrio cholerae O1 in a Cholera Endemic Region Shows It Is a Non-random Process

霍乱流行地区霍乱弧菌O1血清型转换的回顾性分析表明，这是一个非随机过程

PLOS NEGLECTED TROPICAL DISEASES

IF3.4

2016-10-0522

OAAI

Cholera Toxin, and the Related Nontoxic Adjuvants mmCT and dmLT, Promote Human Th17 Responses via Cyclic AMP-Protein Kinase A and Inflammasome-Dependent IL-1 Signaling

JOURNAL OF IMMUNOLOGY

IF3.4

2015-04-1566

PREAI

Carbohydrate binding specificities and crystal structure of the cholera toxin-like B-subunit from Citrobacter freundii

IF3

2010-05-0113

PREAI

Intranasal Immunization With an Apolipoprotein B-100 Fusion Protein Induces Antigen-Specific Regulatory T Cells and Reduces Atherosclerosis

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

IF7.4

2010-05-01175

OAAI

Construction and expression of immunogenic hybrid enterotoxigenic Escherichia coli CFA/I and CS2 colonization fimbriae for use in vaccines

APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

IF4.3

2010-04-2018

PREAI